Westhampton Capital, LLC Buys Visa Inc, UnitedHealth Group Inc, Regeneron Pharmaceuticals Inc, Sells FedEx Corp, WestRock Co, iShares Nasdaq Biotechnology Index Fund

• New Purchases: V, REGN,
• Added Positions: PH, UNH, VZ, HAL, BA, KHC, BIIB, CVS, MSFT, BMY, AVGO, CVX, XOM, MMM, IFF, KMI, BBT, QCOM,
• Reduced Positions: KO, CRI, AAPL, IP, HSY, ABBV, MA, ABT, D, BSET, NVDA, UL, IBM, JNJ, MAR, CELG, COP, SPLV, PANW, PSX, BAC,
• Sold Out: FDX, WRK, IBB,

For the details of Westhampton Capital, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/westhampton+capital%2C+llc/current-portfolio/portfolio

1. Apple Inc (AAPL) - 30,844 shares, 5.78% of the total portfolio. Shares reduced by 1.11%
2. Carter's Inc (CRI) - 58,905 shares, 4.50% of the total portfolio. Shares reduced by 1.67%
3. The Walt Disney Co (DIS) - 31,893 shares, 3.48% of the total portfolio. Shares reduced by 0.42%
4. Procter & Gamble Co (PG) - 32,184 shares, 3.35% of the total portfolio. Shares reduced by 0.81%
5. Clorox Co (CLX) - 25,843 shares, 3.28% of the total portfolio. Shares reduced by 0.38%

Westhampton Capital, LLC initiated holding in Visa Inc. The purchase prices were between $168.86 and $185.74, with an estimated average price of $178.14. The stock is now traded at around $178.11. The impact to a portfolio due to this purchase was 0.22%. The holding were 1,510 shares as of .

Westhampton Capital, LLC initiated holding in Regeneron Pharmaceuticals Inc. The purchase prices were between $273.46 and $318.39, with an estimated average price of $296.17. The stock is now traded at around $298.82. The impact to a portfolio due to this purchase was 0.17%. The holding were 750 shares as of .

Westhampton Capital, LLC added to a holding in UnitedHealth Group Inc by 90.30%. The purchase prices were between $215.26 and $266.65, with an estimated average price of $241.24. The stock is now traded at around $236.40. The impact to a portfolio due to this purchase was 0.19%. The holding were 2,276 shares as of .

Westhampton Capital, LLC added to a holding in Halliburton Co by 74.50%. The purchase prices were between $17.31 and $23.85, with an estimated average price of $20.7. The stock is now traded at around $18.39. The impact to a portfolio due to this purchase was 0.11%. The holding were 15,600 shares as of .

Westhampton Capital, LLC added to a holding in The Kraft Heinz Co by 34.39%. The purchase prices were between $25 and $32.53, with an estimated average price of $28.76. The stock is now traded at around $27.45. The impact to a portfolio due to this purchase was 0.09%. The holding were 15,435 shares as of .

Westhampton Capital, LLC added to a holding in Biogen Inc by 31.20%. The purchase prices were between $217.44 and $243.88, with an estimated average price of $232.74. The stock is now traded at around $228.40. The impact to a portfolio due to this purchase was 0.08%. The holding were 1,640 shares as of .

Westhampton Capital, LLC added to a holding in CVS Health Corp by 21.01%. The purchase prices were between $54.09 and $64.3, with an estimated average price of $59.22. The stock is now traded at around $65.49. The impact to a portfolio due to this purchase was 0.07%. The holding were 7,920 shares as of .

Westhampton Capital, LLC sold out a holding in FedEx Corp. The sale prices were between $143.25 and $176.01, with an estimated average price of $161.2.

Westhampton Capital, LLC sold out a holding in WestRock Co. The sale prices were between $32.31 and $39.09, with an estimated average price of $35.73.

Westhampton Capital, LLC sold out a holding in iShares Nasdaq Biotechnology Index Fund. The sale prices were between $99.3 and $110.93, with an estimated average price of $104.75.